📖
Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia?
Özdemir SA, Açıkgöz E, Çelik A, Yılmaz O, Sarper M, Garip G, Özer E, Öktem G

Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia?

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Ital J Pediatr.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia?
Author / Organization Özdemir SA, Açıkgöz E, Çelik A, Yılmaz O, Sarper M, Garip G, Özer E, Öktem G
Subject & Discipline Ital J Pediatr
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-33445
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »